Tripathy, D., Bardia, A., & Sellers, W. R. (2017). Ribociclib (LEE011): Mechanism of action and clinical impact of this selective cyclin-dependent kinase 4/6 inhibitor in various solid tumors. Clin Cancer Res.
Chicago-tyylinen lähdeviittausTripathy, Debu, Aditya Bardia, ja William R. Sellers. "Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-dependent Kinase 4/6 Inhibitor in Various Solid Tumors." Clin Cancer Res 2017.
MLA-viiteTripathy, Debu, Aditya Bardia, ja William R. Sellers. "Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-dependent Kinase 4/6 Inhibitor in Various Solid Tumors." Clin Cancer Res 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.